Robeco Institutional Asset Management’s Pacira BioSciences PCRX Stock Holding History

Robeco Institutional Asset Management’s Portfolio PCRX Stock Details PCRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$4.16M	Buy	164,014 +5,918	+4%	+$140K	0.01%	566
2026 Q1	$3.57M	Buy	158,096 +104,091	+193%	+$2.31M	0.01%	594
2025 Q4	$1.4M	Hold	54,005	–	–	﹤0.01%	697
2025 Q3	$1.39M	Hold	54,005	–	–	﹤0.01%	728
2025 Q2	$1.29M	Sell	54,005 -28,689	-35%	-$723K	﹤0.01%	736
2025 Q1	$2.05M	Buy	82,694 +12,750	+18%	+$305K	﹤0.01%	704
2024 Q4	$1.32M	Hold	69,944	–	–	﹤0.01%	758
2024 Q3	$1.05M	Buy	+69,944	New	+$1.2M	﹤0.01%	781

Other funds holding PCRX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

DPCM

Doma Perpetual Capital Management Miami, Florida $431M AUM 13.21% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Robeco Institutional Asset Management's PCRX Position: Q2 2026 in Review

Robeco Institutional Asset Management increased its Pacira BioSciences (PCRX) stake by 3.7% in Q2 2026, buying an estimated $140K and bringing the position to 164,014 shares worth $4.16M. The position accounts for 0.01% of the portfolio, ranked #566.

Robeco Institutional Asset Management first reported a position in PCRX in Q3 2024 and has held it in 8 quarters since. 253 funds tracked by Wall St. Rank hold PCRX as of Q2 2026.

Robeco Institutional Asset Management held 164,014 shares of Pacira BioSciences worth $4.16M as of Q2 2026.
Robeco Institutional Asset Management bought 5,918 Pacira BioSciences shares in Q2 2026, an estimated $140K.
Pacira BioSciences made up 0.01% of Robeco Institutional Asset Management's portfolio in Q2 2026, its #566 holding.
Robeco Institutional Asset Management first reported a position in Pacira BioSciences in Q3 2024 and has held it in 8 quarters since.
253 funds tracked by Wall St. Rank held Pacira BioSciences as of Q2 2026.

Based on Robeco Institutional Asset Management's 13F filing for Q2 2026, filed 21 Jul 2026.